← Leaderboards
Kenneth E Sherman
University Of Cincinnati
$13,511,782
Attributed
$13,511,782
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $898.6K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$13,511,782 · 11
By mechanism
R01$9,779,250 · 3
K24$1,415,025 · 1
R34$712,728 · 1
R56$534,653 · 1
R21$443,976 · 1
M01$319,263 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Mohamed Tarek Mohamed Shata$399,926
- Erin N Haynes$11,193,350
Others in their field
Top investigators on “Liver Diseases”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Larry Arthur$49,271,333
Research focus
Liver DiseasesEtiologyMorbidity - Disease RateLiverHiv InfectionsHepatitis C VirusInnovationDesignUnited States National Institutes Of HealthAlcoholsResearch PersonnelLiver FibrosisFundingInjuryHepatitis CMortality Vital StatisticsSamplingStagingGrantCirrhosisBaseHepatitis B VirusPharmaceutical PreparationsDiagnosis
Grant awards (50)
HIV and Liver Disease Conference$35,000
R13 · FY2023 · AI · contact PI
Biomarkers of Replication and Injury in HBV/HIV$207,318
R21 · FY2022 · AI · contact PI
HIV and Liver Disease Conference$1
R13 · FY2022 · AI · contact PI
Biomarkers of Replication and Injury in HBV/HIV$236,658
R21 · FY2021 · AI · contact PI
HIV and Liver Disease Conference$30,000
R13 · FY2021 · AI · contact PI
HIV Antiretroviral Therapy and Hepatic Injury$500,044
R01 · FY2019 · AI · contact PI
Hepatitis E in HIV-Infected Patients$274,999
R01 · FY2019 · DK · contact PI
HIV Antiretroviral Therapy and Hepatic Injury$500,044
R01 · FY2018 · AI · contact PI
Hepatitis E in HIV-Infected Patients$274,999
R01 · FY2018 · DK · contact PI
Liver Disease and HIV$25,000
R13 · FY2018 · AI · contact PI
HIV Antiretroviral Therapy and Hepatic Injury$549,499
R01 · FY2017 · AI · contact PI
Hepatitis E in HIV-Infected Patients$274,999
R01 · FY2017 · DK · contact PI
HIV Antiretroviral Therapy and Hepatic Injury$562,690
R01 · FY2016 · AI · contact PI
Hepatitis E in HIV-Infected Patients$274,999
R01 · FY2016 · DK · contact PI
Liver Disease and HIV$40,000
R13 · FY2016 · AI · contact PI
Hepatitis E in HIV-Infected Patients$274,999
R01 · FY2015 · DK · contact PI
HIV Antiretroviral Therapy and Hepatic Injury$534,653
R56 · FY2014 · AI · contact PI
Mentorship in Liver Disease$156,645
K24 · FY2014 · DK · contact PI
Liver Disease and HIV$32,000
R13 · FY2014 · AI · contact PI
Viral kinetic models of HCV clearance in hemophiliacs treated with telaprevir$340,577
R34 · FY2013 · HL · contact PI
Mentorship in Liver Disease$156,812
K24 · FY2013 · DK · contact PI
Liver Disease and HIV$5,900
R13 · FY2013 · AI · contact PI
Viral kinetic models of HCV clearance in hemophiliacs treated with telaprevir$372,151
R34 · FY2012 · HL · contact PI
Mentorship in Liver Disease$156,968
K24 · FY2012 · DK · contact PI
Liver Disease and HIV$40,000
R13 · FY2012 · AI · contact PI
Mentorship in Liver Disease$157,116
K24 · FY2011 · DK · contact PI
Antiretroviral Therapy and the Hepatitis C Virus$552,261
R01 · FY2010 · AI · contact PI
Mentorship in Liver Disease$157,265
K24 · FY2010 · DK · contact PI
Mentorship in Liver Disease$47,000
K24 · FY2010 · DK · contact PI
Liver Disease and HIV$41,934
R13 · FY2010 · AI · contact PI
Antiretroviral Therapy and the Hepatitis C Virus$774,020
R01 · FY2009 · AI · contact PI
Mentorship in Liver Disease$117,084
K24 · FY2009 · DK · contact PI
Liver Disease and HIV$1,036
R13 · FY2009 · AI · contact PI
Antiretroviral Therapy and the Hepatitis C Virus$686,648
R01 · FY2008 · AI · contact PI
Mentorship in Liver Disease$117,084
K24 · FY2008 · DK · contact PI
ANTIRETROVIRAL THERAPY AND HCV/HIV$63,816
M01 · FY2008 · RR · contact PI
Liver Disease and HIV$31,016
R13 · FY2008 · AI · contact PI
Antiretroviral Therapy and the Hepatitis C Virus$696,735
R01 · FY2007 · AI · contact PI
Mentorship in Liver Disease$117,084
K24 · FY2007 · DK · contact PI
Antiretroviral Therapy and the Hepatitis C Virus$710,063
R01 · FY2006 · AI · contact PI
Mentorship in Liver Disease$117,084
K24 · FY2006 · DK · contact PI
Liver Disease and HIV$25,000
R13 · FY2006 · AI · contact PI
RESPONSE OF HEPATITIS C VIRUS TO INTERFERON IN HEMOPHILIC PATIENTS$15,792
M01 · FY2006 · RR · contact PI
Mentorship in Liver Disease$114,883
K24 · FY2005 · DK
RESPONSE OF HEPATITIS C VIRUS TO INTERFERON IN HEMOPHILIC PATIENTS$53,010
M01 · FY2005 · RR
HCV Genomic Variability in HIV Infected Hemophiliacs$722,752
R01 · FY2004 · AI
Hepatitis C Virus Response to Interferon in Hemophilia$186,645
M01 · FY2004 · RR
HCV Genomic Variability in HIV Infected Hemophiliacs$703,465
R01 · FY2003 · AI
HCV Genomic Variability in HIV Infected Hemophiliacs$689,116
R01 · FY2002 · AI
HCV Genomic Variability in HIV Infected Hemophiliacs$756,918
R01 · FY2001 · AI